Conjugated bilirubin
Reactions involving Conjugated bilirubin
Every recorded step where this molecule takes part
-
consumed Bacterial beta-glucuronidases + reductases (gut microbiota) Heme Degradation (Bilirubin Pathway) ST-0189
Conjugated bilirubin → unconjugated bilirubin → urobilinogen
Showing all 1 reactions.
Recent literature
Europe PMC · from cache · sorted by publication date
-
1
Analytical and clinical validation of a competitive ELISA for serum indoxyl sulfate and its clinical association with chronic kidney disease risk stratification.
Hou YC, Chuang YC, Cheng YW, Huang HY, Chen LY, Tseng TL, Lu KC. · 2026-06-02
open access unreviewed -
2
Association Between Gut Microbiota Dysbiosis and Bilirubin Metabolism Dysregulation in Children with Heart Failure.
Wei W, Zhou L, Huang Y, Lu Z, Zhang R, Zeng M, Wang X. · 2026-08-13
unreviewed -
3
Prolonged cholestasis following severe neonatal echovirus 11 (genotype D5, new lineage 1) infection diagnosed by serum detection.
Ogawa E, Mizutani H, Okumura T, Ikeyama T, Ikuse T, Aizawa Y, Ito K. · 2026-06-16
unreviewed -
4
Characteristics of patients with neonatal intrahepatic cholestasis caused by citrin deficiency in China: long-term follow-up outcomes.
Chen L, Lou J, Luo Y, Fang Y, Sun M, Yu J. · 2026-05-19
open access unreviewed -
5
Platelet Drp1 phosphorylation provides a platform for immune-based platelet function testing.
Barrios DA, Guo S, Powers M, Koseoglu S, Zerbey S, Lu R, Cermak A, Vayne C, Khan S, Aisiku O, Urman A, Thomas… · 2026-07-01
cited 1× unreviewed -
6
Pediatric Sjögren’s Disease: Literature Review and Diagnostic Challenges in an Uncommon Case
· 2026-06-01
open access unreviewed -
7
Flavonoids as Nutraceuticals to Treat Inflammatory Diseases: Focusing on Quercetin, Kaempferol, Luteolin, Apigenin, Epicatechin and Their Effects on Hepatic, Nervous, and Pulmonary Systems
Piva M, Martelossi-Cebinelli G, Mendes-Pierotti S, Chinen W, Cardines P, Martinez R, Georgetti S, Baracat M, … · 2026-06-01
open access unreviewed - 8
- 9
-
10
Conjugated bilirubin reduces hepatitis E virus infectivity by modulating immunometabolic processes.
Orozco-Cordoba J, Anaya-Covarrubias JY, Santiago MD, Zamora D, Roman S, Panduro A, Carrero JC, Fierro NA. · 2026-06-01
unreviewed
External claims. These come from an index outside this database and are not checked against it. Treat them as leads.